Islet Transplantation : NIDDK

Islet Transplantation

The Islet Transplantation Program encompasses therapeutic or preclinical studies in the following areas:

  • Studies to optimize islet yield, viability and durability in the procurement and pre-transplant process.
  • Use of immunoisolation techniques, small molecule and gene therapy or other manipulations that enhance islet graft survival
  • Therapies to promote immune tolerance of islet grafts
  • Evaluation of novel immunosuppressive reagents, regimens or adjunct therapeutics that promote islet graft survival
  • Mechanistic studies that specifically contribute to understanding islet graft survival and beta cell renewal
  • Studies that evaluate alternatives to human islets for transplantation

For more information, contact Dr. Michael Appel, Director, Islet Biology and Transplantation Research Program.

Resources for Researchers

Clinical Research


Committees and Advisory Groups

Related Study Sections


Funding Opportunities

Funding for Special Communities


Related Reports

Related Organizations

See Also

Page last updated: January 05, 2009

General inquiries may be addressed to: Office of Communications & Public Liaison
Building 31. Rm 9A06
31 Center Drive, MSC 2560
Bethesda, MD 20892-2560
For information about NIDDK programs: 301.496.3583

The National Institutes of Health   Department of Health and Human Services is the U.S. government's official web portal to all federal, state, and local government web resources and services.  HONcode Seal - Link to the Health on the Net Foundation